-- Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise and efficient recombinases with Lilly’s extensive development ...
Dresden, Germany, and Lexington, MA, January 28, 2026 - Seamless Therapeutics announced today that it has entered into a strategic global research collaboration and licensing agreement with Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results